Semaglutide is approved as a long-term medication for weight loss, with no built-in stop date. The FDA labels it for use “long term” in combination with diet and exercise, and major medical organizations treat obesity as a chronic condition requiring ongoing pharmacotherapy. In practice, this means most people who respond well to semaglutide stay on it indefinitely, much like someone might stay on blood pressure medication for years.
That said, “indefinitely” doesn’t mean there’s no nuance. Your timeline depends on how your body responds, whether you can tolerate the medication, what your insurance requires, and what happens if you stop.
The First 16 Weeks: Dose Escalation
You don’t start at the full dose. Semaglutide follows a gradual ramp-up schedule over about four months to reduce nausea and other gastrointestinal side effects. The standard Wegovy schedule looks like this:
- Weeks 1 through 4: 0.25 mg once weekly
- Weeks 5 through 8: 0.5 mg once weekly
- Weeks 9 through 12: 1 mg once weekly
- Weeks 13 through 16: 1.7 mg once weekly
- Week 17 onward: 1.7 mg or 2.4 mg maintenance dose
If side effects are hard to manage at any step, the escalation can be paused for an additional four weeks before moving up. Some people take five or six months to reach their maintenance dose. You’ll likely notice appetite suppression early on, but the full weight loss effect builds over months as you reach the higher doses.
What Two Years of Treatment Looks Like
The longest major clinical trial for semaglutide at the weight loss dose ran for 104 weeks, or two full years. In that trial (known as STEP 5), participants taking the 2.4 mg dose lost an average of 15.2% of their body weight, compared to 2.6% for those on placebo. That’s roughly 35 to 40 pounds for someone starting at 240 pounds.
Weight loss with semaglutide tends to follow a curve: most of the loss happens in the first year, then gradually levels off into a maintenance phase during the second year. This plateau isn’t a sign the medication stopped working. It reflects the body reaching a new equilibrium where the drug’s appetite-suppressing effects balance against the body’s natural drive to defend its weight.
Why Stopping Often Leads to Weight Regain
This is the part most people searching this question really want to understand. When you stop semaglutide, the weight typically comes back. This isn’t a failure of willpower. The medication works partly by mimicking a gut hormone that signals fullness to the brain, and it may also reset certain hormonal and appetite pathways over time. When you remove the drug, those signals change back, hunger returns to pre-treatment levels, and the body’s metabolic adaptations push weight upward.
Research suggests these physiological changes, including shifts in appetite hormones and brain signaling around hunger, are sustained adaptations that don’t simply resolve once treatment ends. This is the core reason obesity specialists view semaglutide as a long-term treatment rather than a short course you complete and move on from. The underlying biology that drives weight gain doesn’t disappear because you lost weight on a medication.
Insurance Requirements for Continued Coverage
Even though the medical recommendation is long-term use, insurance plans often impose their own timelines. Many require periodic reauthorization, typically every 6 to 12 months, and you’ll need to show the medication is working to keep your coverage.
Common renewal requirements include demonstrating at least a 5% reduction in BMI from your starting point, proof that you’re following a weight loss plan (such as dietary changes or exercise), and confirmation from your prescriber that you’ve been taking the medication consistently. For adolescents, some programs set the bar lower at 1% BMI reduction. If you don’t meet these thresholds, your plan may deny continued coverage, which can force a conversation with your doctor about next steps.
Cost without insurance is substantial, often over $1,000 per month, so these renewal criteria effectively create checkpoints that influence how long you stay on treatment regardless of the medical recommendation.
Long-Term Safety Considerations
Staying on any medication for years raises reasonable concerns about side effects. The most common issues with semaglutide are gastrointestinal: nausea, diarrhea, constipation, and occasional vomiting. These tend to be worst during dose escalation and improve over time for most people.
One concern that comes up frequently is pancreatitis. A large meta-analysis covering more than 34,000 patients found no increased risk of acute pancreatitis with semaglutide use across any dose. The drug does carry a label warning about a rare thyroid cancer (medullary thyroid carcinoma) based on animal studies, and it’s not recommended for anyone with a personal or family history of that specific cancer or a related genetic condition called MEN2. Beyond those caveats, the safety profile over two years of trial data has been reassuring enough for regulatory agencies to approve it without a treatment duration limit.
When Some People Do Stop
Not everyone stays on semaglutide forever. Some people stop because of persistent side effects that don’t resolve, loss of insurance coverage, cost, or a personal decision that they’ve built enough sustainable habits to manage their weight independently. Others transition to a lower dose if their prescriber offers that option, since the 1.7 mg maintenance dose is an approved alternative to the full 2.4 mg.
If you and your doctor decide to stop, the transition should be gradual and paired with a realistic plan. Intensifying exercise, working with a dietitian, and monitoring your weight closely in the months after stopping can help, though it may not fully prevent regain. Some people restart the medication after regaining a certain amount of weight, treating it more like an intermittent tool than a one-time course.
The honest answer is that semaglutide works best as an ongoing treatment, and stopping it usually means losing much of the benefit. How long you personally stay on it will come down to a combination of how well it works for you, how well you tolerate it, and whether you can maintain access to it.